Ceftazidime Antibody Screening by Immunoassay (Plasma/Serum)
This test measures the presence of antibodies in your blood that may react to the antibiotic ceftazidime, often used to treat bacterial infections.
["Helps identify potential immune responses to this antibiotic, which could affect treatment decisions."]
Key facts at a glance
- LOINC
- 90850-9
- Short code
- CTZ-SLM-1.0
- Synonyms
- cefTAZidime Islt Slgr Mcbct AB 1.0
- Category
- chemistry
- Sample
- serum
- Container
- Sterile, leak-proof container; mycobacterial culture transport medium or sterile screw-capped tube for clinical specimens (sputum, BAL, tissue, body fluid)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- method-for-slow-growing-mycobacteria-antibiotic-concentration-at-ug-ml
- CPT
- 87190
- SNOMED
- 40675000
- Specimen volume
- Variable based on specimen type; minimum 1-5 mL for body fluids; 5-10 mL for sputum or BAL
- Stability
- Specimens should be processed within 24 hours of collection if held at room temperature, or refrigerated at 2-8°C for up to 7 days. Isolates for susceptibility testing should be subcultured and maintained on appropriate media.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 168–720 hours
- Order
- routine
Why This Test Might Be Ordered
Your healthcare provider may order this test if you’ve been exposed to ceftazidime or have a suspected allergic reaction, or if you’re considering this antibiotic for treatment. It can also be used in research or specialized clinical settings to study immune responses to antibiotics.
What to Expect Before the Test
No special preparation is needed. You’ll likely have a simple blood draw from a vein in your arm. If you’re taking ceftazidime, inform your provider beforehand, as this may influence results.
What the Test Results Mean
Results are qualitative (positive/negative) and indicate whether your immune system has detected antibodies against ceftazidime. A positive result suggests an immune response, which may require further evaluation by your doctor.
Common Reasons for Testing
This test is less commonly performed in routine clinical practice but may be used in specialized cases, such as allergy testing, drug hypersensitivity studies, or research involving antibiotic exposure.
Reference range
Results reported as Susceptible (S), Intermediate (I), or Resistant (R) based on growth/no growth at 1.0 ug/mL ceftazidime. Slow-growing mycobacteria are generally considered resistant to ceftazidime; this test is used for research or specific clinical correlation.N/A
No patient preparation required. Specimen should be collected prior to initiation of antimycobacterial therapy when possible. Ensure specimen is collected aseptically to avoid contamination with normal flora.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Antibody detection against ceftazidime can inform decisions about alternative antibiotics if cross-reactivity or allergic concerns are suspected. It may also help in monitoring immune responses in clinical trials or rare cases of drug-related immune reactions.
Short name
Ceftazidime Antibody Test
Frequently asked questions
Will this test show if I have an allergy to ceftazidime?
Can I still take ceftazidime if my test is positive?
How long does it take to get results?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy